Company: SYRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001641172-25-023235
Chunk: 61

Company: Syra Health Corp
Filing Date: 2025-08-12
Form: 10-Q
Item: Item 8
Chunk 61
---
 through the date these financial statements were issued.

On
July 1, 2025, the Company entered into a consulting agreement with a former member of the Board of Directors for services related to
developing a new strategic plan for the Company and identifying and hiring a new CEO. The agreement is in effect through September 30,
2025, and allows for a monthly cash fee of $5,000 per month, and awarded 25,000 Class A common stock options and 25,000 restricted stock
units (“RSU’s”) of the Company’s Class A common stock to the consultant. Both the options and RSU’s fully
vest upon Board approval of the new strategic plan and delivery of final CEO recommendations to the Board. The stock options and RSU’s
will also vest in the event of a change of control of the Company.

On
July 28, 2025, Deepika Vuppalanchi resigned from the Board of Directors of Syra Health Corp. for personal reasons.

F-16

ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

You
should read the following discussion and analysis of our financial condition and results of operations together with our unaudited interim
condensed financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical
information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our
actual results may differ materially from those discussed below. Factors that could cause or contribute to such differences include,
but are not limited to, those identified below, and those discussed in the section titled “Risk Factors” included in this
Quarterly Report on Form 10-Q, as may be amended, supplemented or superseded from time to time by other reports we file with the SEC.
All amounts in this report are in U.S. dollars, unless otherwise noted.

Throughout
this Quarterly Report on Form 10-Q, references to “we,” “our,” “us,” the “Company,” or
“Syra,” refer to Syra Health Corp.

Overview

We
are a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all
patient demographics. We leverage deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric
solutions for the betterment of patient lives and health outcome linked to developing a healthier population. We are developing comprehensive
end-to-end solutions in population health, behavioral